UK markets open in 3 hours 3 minutes
NIKKEI 225
38,051.16 +422.68 (+1.12%) HANG SENG
17,592.90 +308.36 (+1.78%) CRUDE OIL
83.80 +0.23 (+0.28%) GOLD FUTURES
2,344.60 +2.10 (+0.09%) DOW
38,085.80 -375.12 (-0.98%) Bitcoin GBP
51,502.15 +52.62 (+0.10%)
Relmada Therapeutics, Inc. (RLMD)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 3.8600 |
| Open | 3.7900 |
| Bid | 3.6800 x 100 |
| Ask | 3.7400 x 500 |
| Day's range | 3.6600 - 3.7950 |
| 52-week range | 2.3600 - 7.2230 |
| Volume | |
| Avg. volume | 215,477 |
| Market cap | 116.472M |
| Beta (5Y monthly) | 0.19 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.1400 |
| Earnings date | 09 May 2024 - 13 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 10.88 |
Insider MonkeyRelmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2023 Earnings Call Transcript
Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2023 Earnings Call Transcript March 19, 2024 Relmada Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.84, expectations were $-0.88. RLMD isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and gentlemen, and […]
- Thomson Reuters StreetEvents
Q4 2023 Relmada Therapeutics Inc Earnings Call
Q4 2023 Relmada Therapeutics Inc Earnings Call
- GuruFocus.com
Relmada Therapeutics Inc Reports Full-Year and Q4 2023 Financial Results
Progress in CNS Treatments Amid Financial Challenges
© 2024 Yahoo. All rights reserved.